Literature DB >> 33270907

Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case-control design.

Yei Eun Shin1, Ruth M Pfeiffer1, Barry I Graubard1, Mitchell H Gail1.   

Abstract

We study the efficiency of covariate-specific estimates of pure risk (one minus the survival function) when some covariates are only available for case-control samples nested in a cohort. We focus on the semiparametric additive hazards model in which the hazard function equals a baseline hazard plus a linear combination of covariates with either time-varying or time-invariant coefficients. A published approach uses the design-based inclusion probabilities to reweight the nested case-control data. We obtain more efficient estimates of pure risks by calibrating the design weights to data available in the entire cohort, for both time-varying and time-invariant covariate coefficients. We develop explicit variance formulas for the weight-calibrated estimates based on influence functions. Simulations show the improvement in precision by using weight calibration and confirm the consistency of variance estimators and the validity of inference based on asymptotic normality. Examples are provided using data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study (PLCO).
© 2020 The International Biometric Society.

Entities:  

Keywords:  additive hazards model; influence functions; nested case-control design; pure risk; two-phase sampling design; weight calibration

Mesh:

Year:  2020        PMID: 33270907      PMCID: PMC8172655          DOI: 10.1111/biom.13413

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  11 in total

1.  Comparison of estimators in nested case-control studies with multiple outcomes.

Authors:  Nathalie C Støer; Sven Ove Samuelsen
Journal:  Lifetime Data Anal       Date:  2012-03-02       Impact factor: 1.588

2.  Using the whole cohort in the analysis of case-cohort data.

Authors:  Norman E Breslow; Thomas Lumley; Christie M Ballantyne; Lloyd E Chambless; Michal Kulich
Journal:  Am J Epidemiol       Date:  2009-04-08       Impact factor: 4.897

3.  Connections between survey calibration estimators and semiparametric models for incomplete data.

Authors:  Thomas Lumley; Pamela A Shaw; James Y Dai
Journal:  Int Stat Rev       Date:  2011-08       Impact factor: 2.217

4.  Inverse probability weighting in nested case-control studies with additional matching--a simulation study.

Authors:  Nathalie C Støer; Sven Ove Samuelsen
Journal:  Stat Med       Date:  2013-10-17       Impact factor: 2.373

5.  On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.

Authors:  S Vansteelandt; T Martinussen; E Tchetgen Tchetgen
Journal:  Biometrika       Date:  2013-11-21       Impact factor: 2.445

6.  A linear regression model for the analysis of life times.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

7.  Weight calibration to improve the efficiency of pure risk estimates from case-control samples nested in a cohort.

Authors:  Yei Eun Shin; Ruth M Pfeiffer; Barry I Graubard; Mitchell H Gail
Journal:  Biometrics       Date:  2020-01-02       Impact factor: 2.571

8.  A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.

Authors:  Steven C Moore; Mary C Playdon; Joshua N Sampson; Robert N Hoover; Britton Trabert; Charles E Matthews; Regina G Ziegler
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

9.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

10.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.